Skip to main content
Clinical Trials/NCT01220479
NCT01220479CompletedNot Applicable

Impact of an Exercise Training Program on Bone Development and Cardiovascular Disease Risk Factors in Children With Type 1 Diabetes Mellitus

University Hospital, Geneva1 site in 1 country59 target enrollmentStarted: September 1, 2001Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
59
Locations
1
Primary Endpoint
Bone mineral density and content

Study Overview

Brief Summary

Type 1 diabetes mellitus (T1DM) is associated with multiple co-morbidities, such as hypertension, dyslipidemia, coronary heart disease and osteoporosis. The foundation of these conditions lays in childhood. Exercise is known to have a positive influence on bone mineral density (BMD) and some impact on cardiovascular disease risk factors in healthy children, but little is known about these associations in children with T1DM.

The main purpose of this study is to assess the effects of a 9-month weight-bearing exercise training program on skeletal development in children with T1DM, compared to healthy subjects. The second aim is to evaluate whether the program influences also cardiovascular diseases risk factors.

This is a randomized controlled study incorporating 30 children with T1DM and 30 healthy children. Both groups are randomly divided (1:1) in an exercise or a control group: 1) exercise diabetic, 2) controls diabetic, 3) exercise healthy, 4) controls healthy.

Exercise groups participate to an identical weight-bearing exercise training program 2 x 90 minutes per week and controls are relatively inactive.

Main measures include: total body, lumbar spine and hip BMD by DXA, body fat and fat-free mass, bone biomarkers levels, resting and ambulatory blood pressure and fasting blood lipids.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
8 Years to 16 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •List of inclusion criteria for Type 1 diabetes patients:
  • •disease for at least 1 year.
  • •List of inclusion criteria for healthy subjects:
  • •good general health and normal growth.

Exclusion Criteria

  • •for all subjects:
  • •presence of other chronic disease, including thyroid disease;
  • •medications, hormones other than insulin, or calcium preparations taken in the preceding 6 months;
  • •presence of nephropathy;
  • •systemic disease or hospitalization for more than 2 weeks in the preceding year;
  • •less than 6 menstrual cycles in the past year for post-menarche girls;
  • •participation in competitive sport.

Arms & Interventions

Control Diabetic

No Intervention

Intervention: Exercise training program (Behavioral)

Control Healthy

No Intervention

Intervention: Exercise training program (Behavioral)

Exercise Diabetic

Experimental

Intervention: Exercise training program (Behavioral)

Exercise Healthy

Experimental

Intervention: Exercise training program (Behavioral)

Outcomes

Primary Outcomes

Bone mineral density and content

Time Frame: at 9 months

Assessment of bone mineral density (BMD) and content (BMC) at the whole body, hip and lumbar spine using DXA.

Bone mineral density and content

Time Frame: Baseline

Assessment of bone mineral density (BMD) and content (BMC) at the whole body, hip and lumbar spine using DXA.

Secondary Outcomes

  • Anthropometrics(at 9 months)
  • Blood lipids levels(at 9 months)
  • Physical activity(at 9 months)
  • Nutrition(at 9 months)
  • Circulating bone biomarkers levels(at 9 months)
  • Glycated Haemoglobin(at 9 months)
  • Systemic blood pressure(at 9 months)
  • Body composition(at 9 months)
  • Anthropometrics(Baseline)
  • Blood lipids levels(Baseline)
  • Physical activity(Baseline)
  • Nutrition(Baseline)
  • Circulating bone biomarkers levels(Baseline)
  • Glycated Haemoglobin(Baseline)
  • Systemic blood pressure(Baseline)
  • Body composition(Baseline)
  • Glycated Haemoglobin(at 3 months)
  • Glycated Haemoglobin(at 6 months)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials